| Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard Journal of clinical oncology 27 (12), 1992-1998, 2009 | 771 | 2009 |
| The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis J Bartkova, J Lukas, P Guldberg, J Alsner, AF Kirkin, J Zeuthen, J Bartek Cancer Research 56 (23), 5475-5483, 1996 | 386 | 1996 |
| FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial LS Mortensen, J Johansen, J Kallehauge, H Primdahl, M Busk, P Lassen, ... Radiotherapy and oncology 105 (1), 14-20, 2012 | 343 | 2012 |
| Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind … J Overgaard, JG Eriksen, M Nordsmark, J Alsner, MR Horsman The lancet oncology 6 (10), 757-764, 2005 | 313 | 2005 |
| Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations M Nordsmark, J Alsner, J Keller, OS Nielsen, OM Jensen, MR Horsman, ... British Journal of Cancer 84 (8), 1070-1075, 2001 | 304 | 2001 |
| Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer K Toustrup, BS Sørensen, M Nordsmark, M Busk, C Wiuf, J Alsner, ... Cancer research 71 (17), 5923-5931, 2011 | 280 | 2011 |
| Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes CN Andreassen, J Alsner, M Overgaard, J Overgaard Radiotherapy and Oncology 69 (2), 127-135, 2003 | 274 | 2003 |
| A technical assessment of the utility of reverse phase protein arrays for the study of the functional proteome in non-microdissected human breast cancers BT Hennessy, Y Lu, AM Gonzalez-Angulo, MS Carey, S Myhre, Z Ju, ... Clinical proteomics 6 (4), 129-151, 2010 | 273 | 2010 |
| Does variability in normal tissue reactions after radiotherapy have a genetic basis–where and how to look for it? CN Andreassen, J Alsner, J Overgaard Radiotherapy and Oncology 64 (2), 131-140, 2002 | 259 | 2002 |
| HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer P Lassen, JG Eriksen, S Hamilton-Dutoit, T Tramm, J Alsner, J Overgaard Radiotherapy and Oncology 94 (1), 30-35, 2010 | 241 | 2010 |
| Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck K Toustrup, BS Sørensen, P Lassen, C Wiuf, J Alsner, J Overgaard Radiotherapy and Oncology 102 (1), 122-129, 2012 | 234 | 2012 |
| Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial BV Offersen, J Alsner, HM Nielsen, EH Jakobsen, MH Nielsen, M Krause, ... Journal of Clinical Oncology 38 (31), 3615-3625, 2020 | 228 | 2020 |
| Genetic variants and normal tissue toxicity after radiotherapy: a systematic review CN Andreassen, J Alsner Radiotherapy and oncology 92 (3), 299-309, 2009 | 215 | 2009 |
| Establishment of a radiogenomics consortium C West, BS Rosenstein International journal of radiation oncology, biology, physics 76 (5), 1295-1296, 2010 | 195 | 2010 |
| Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer R Agarwal, AM Gonzalez-Angulo, S Myhre, M Carey, JS Lee, J Overgaard, ... Clinical cancer research 15 (11), 3654-3662, 2009 | 188 | 2009 |
| Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription C Bendixen, B Thomsen, J Alsner, O Westergaard Biochemistry 29 (23), 5613-5619, 1990 | 177 | 1990 |
| Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: uncoupling the DNA binding, cleavage and religation events BS Sørensen, J Sinding, AH Andersen, J Alsner, PB Jensen, ... Journal of molecular biology 228 (3), 778-786, 1992 | 166 | 1992 |
| Activation of peroxisome proliferator-activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation JB Hansen, RK Petersen, BM Larsen, J Bartkova, J Alsner, K Kristiansen Journal of Biological Chemistry 274 (4), 2386-2393, 1999 | 162 | 1999 |
| HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary … A Linge, F Lohaus, S Löck, A Nowak, V Gudziol, C Valentini, ... Radiotherapy and Oncology 121 (3), 364-373, 2016 | 159 | 2016 |
| TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer CN Andreassen, J Alsner, J Overgaard, C Herskind, J Haviland, R Owen, ... Radiotherapy and oncology 75 (1), 18-21, 2005 | 158 | 2005 |
Brita Singers SørensenEmail verificata su oncology.dk